To obtain greater insight into atrial remodeling at the molecular level we analyzed the changes in gene expression in human atrial tissue between patients with chronic atrial fibrillation (AF) and those with normal sinus rhythm (NSR). cDNA microarray analysis was used to identify genes differentially expressed during sustained AF of more than 6 months (n = 9, mean age, 45 ± 12, 6 males and 3 females) as compared to those with NSR (n = 9, mean age, 47 ± 13, 6 males and 3 females). Western blot analysis was performed to confirm the altered gene expression and to establish the changes in protein expression. DNA gel electrophoresis to establish DNA ladder formation, which was associated with apoptosis in response to chronic AF, was performed. Microscopic findings were observed via electron microscopy. In the microarray analysis, out of 8,167 candidate genes, 66 genes showed a significant change in the expression level in the patients with chronic AF, which was in contrast to those with NSR. Among those, 31 genes were consistently downregulated and 35 up-regulated more than 2-fold. The relative amounts of the Bcl-2 and p27 in the atrial tissue were decreased and angiotensin II type 2 (AT2) receptor and p21 were increased in the patients with chronic AF as compared to those with NSR. The atrial cardiomyocytes in chronic AF showed a prominent DNA ladder, which is a biochemical hallmark of apoptosis. The expression of Bcl-2, AT2 receptor, p21, and p27 were consistent with a significant role in the apoptosis of cardiac myocytes in the patients with chronic AF. (Int Heart J 2005; 46: 383-395) 
ATRIAL fibrillation (AF) is known to cause significant changes in the architecture and electrophysiology of atria. [1] [2] [3] [4] [5] In addition, preexisting alterations can provide a morphologic substrate which increases the likelihood of AF occurring in response to triggering. [6] [7] [8] At the molecular level, several AF-related alterations of the atrial tissue are known to be associated with activation of different signal transduction systems. [9] [10] [11] Signal transduction systems provide a dynamic interaction between extracellular cues and intracellular events and, thereby, these molecular pathways are involved in the regulation of gene expression, cell proliferation, hypertrophy, differentiation, migration, and cell death. However, the exact molecular mechanisms underlying various aspects of atrial remodeling still remain unknown. In order to identify factors involved in the electrical and structural remodeling, alterations in the gene expression in the fibrillating human atrium were studied.
METHODS
Cardiac specimens: After obtaining written consent, left atrial appendages were obtained from patients undergoing an open heart surgery procedure such as mitral/aortic valve replacement. Tissue samples were taken from 9 patients with chronic, persistent AF of more than 6 months and from 9 matched patients with no history of AF and NSR. Patients with chronic AF had left and right atrial dilation (> 40 mm), most often associated with an increased systolic pulmonary pressure, indicating long-standing valve disease. Specimens from the left atrial appendage were frozen in liquid nitrogen immediately after excision for further evaluation. RNA isolation: Atrial tissues collected from nine patients in each group were crushed in liquid nitrogen, homogenized, and pooled. For cDNA microarray analysis, the total RNA was extracted using a TRIZOL reagent (InVitrogen, Carlsbad, CA) and purified using an RNeasy total RNA isolation kit (Qiagen, Valencia, CA) according to the manufacturer's instructions. The DNA was digested using an RNase-free DNase set (Qiagen) during the RNA purification. The total RNA was quantified by a spectrophotometer and its integrity was assessed by running it on a denaturing 0.8% agarose gel. Fluorescently-labeled cDNA for the cDNA microarray analysis was prepared by the reverse-transcription of the total RNA in the presence of aminoallyl-dUTP followed by the coupling of Cy3 or Cy5 dyes (Amersham Bioscience, Piscataway, NJ). The TwinChip Human-8K Digital Genomics cDNA microarray was hybridized with the fluorescently-labeled cDNA at 42°C for 16 hours and then washed. After the washing procedure, the DNA chips were scanned using a ScanArray Lite (Perkin-Elmer Life Sciences, Billerica, MA). Scanned images were analyzed with GenePix software (Axon  Vol 46  No 3 Instruments, Union City, CA) to obtain the gene expression ratios. Logged gene expression ratios were normalized by LOWESS regression. 12) Scatter plot analysis was conducted with Microsoft Excel 2000 (Microsoft, Redmond, WA). Significance analysis of the microarray (SAM) was performed for the selection of genes with significant gene expression. 13) The statistical significance of the differential expression of any gene was assessed by computing a q-value for each gene. A permutation procedure was used to determine the q-value, and for each permutation, two-sample t statistics were computed for each gene. Genes were considered differentially expressed when the logarithmic gene expression ratios in four independent hybridizations were more than 1 or less than -1, ie, a 2-fold difference in the expression level, with the q-value being < 0.1. After extraction with phenol and chloroform, the DNA was precipitated with 1.5 vol of ethanol and centrifuged. The pellet was washed with 70% ethanol and resolubilized in an appropriate volume of TE (10 mM Tris-HCl, 1 mM EDTA, pH 7.6). The DNA was quantified by spectrophotometry. Equal amounts of each sample (10 µg) were loaded on 1.5% agarose gels containing 0.5 µg/mL ethidium bromide, alongside 2 µg of a DNA marker (123-bp DNA ladder; Sigma-Aldrich).
DNA laddering was observed under ultraviolet light.
Western blotting: Total protein extracts were prepared by homogenizing atrial tissue in a lysis buffer [50 mM Tris-HCl (pH 7.8) containing 150 mM of NaCl, 1% NP-40, and a protease inhibitor cocktail]. The protein content of each sample was determined using a Pierce BCA kit. Samples (50 µg/lane) were boiled with an SDS loading buffer and then loaded onto a 10% or 12% SDS-PAGE gel and transferred to polyvinylidene difluoride membranes (InVitrogen). After blocking with a kit blocking solution (InVitrogen), the membranes were treated with diluted primary antibodies [anti-Bcl-2 (Oncogene, San Diego, CA), anti-Bax (Oncogene), anti-p21 (BD Bioscience, San Jose, CA), anti-p27 (Santa Cruz Biotechnology, Santa Cruz, CA), anti-AT1 receptor and anti-AT2 receptor (Santa Cruz), and anti-tubulin or anti-α-actin sarcomeric monoclonal antibodies followed by a horseradish peroxidase-conjugated secondary antibody (Santa Cruz Biotechnology, Amersham Bioscience). A signal was detected using the enhanced chemiluminescence detection method (ECL plus; Amersham Bioscience). Densitometric analysis of the Western blot was performed using ImageJ software (NIH, Bethesda, Maryland).
Electron microscopy:
A portion of the atrial tissues was fixed in 4% paraformaldehyde and 1% osmic acid fixatives. The tissues were dehydrated in ethanol successively and embedded in Epon mixtures. Ultrathin sections (70 to 80 nm) were obtained with an ultramicrotome, stained with uranyl acetate and lead citrate, and examined using a JEOL 1200-EX II electron microscope. Statistical analysis: To identify statistically significant changes in the expression between AF and NSR, the Mann-Whitney rank sum test was used. A P value below 0.05 was considered significant. Values are expressed as the mean ± standard deviation.
RESULTS

Clinical characteristics:
Patients with chronic AF had left and right atrial dilatation (> 45 mm), most often associated with an increased systolic pulmonary pressure (> 35 mmHg), indicating long-standing mitral and aortic valve disease. Baseline characteristics were similar between the groups (Table I) . cDNA microarray analysis of the gene expression pattern for chronic atrial fibrillation: Among the 8,167 genes, 66 showed a significant change in the expression level in the left atrial tissue from the chronic AF group in contrast to those from the NSR group. Among these genes, 31 were consistently down-regulated and 35 up-regulated. The genes were classified into several functional categories according to the biological function of the encoded protein using a previously established classification scheme. Table II shows the number of significantly changed genes for the different functional categories. The genes were functionally categorized into cell apoptosis, signal transduction, cell cycle, and immune regulation. 
DNA gel electrophoresis:
To confirm that chronic AF induces apoptosis in atrial cardiomyocytes, the DNA ladder formation by agarose gel electrophoresis was examined. Atrial tissue from the chronic AF group showed a prominent DNA ladder characteristic of apoptosis as compared to those from the NSR group (Figure 1 ).
Western blot: (1) Bcl-2 and Bax
There was no significant change in the relative amount of Bax in atrial tissue from the chronic AF compared to the NSR group (160 ± 21% versus 100 ± 14%; n = 9 in each; P = 0.072). The relative amount of Bcl-2 was significantly reduced in atrial tissue from the chronic AF group compared to the NSR group (17 ± 48% versus 100 ± 23%; n = 9 in each; P = 0.017) ( Figure 2 ).
(2) AT1-R and AT2-R
The relative amount of AT1-R in atrial tissue from chronic AF patients did not change significantly compared with that from the NSR group (76 ± 22% ver- sus 100 ± 32%; n = 9 in each; P = 0.39). The relative amount of AT2-R was significantly increased in atrial tissue from chronic AF patients compared with that from the NSR group (162 ± 16% versus 100 ± 12%; n = 9 in each; P = 0.035) (Figure 3) .
(3) p21 and p27
The relative amount of p21 in atrial tissue from chronic AF patients was significantly increased compared with that from the NSR group (258 ± 25% versus 100 ± 17%; n = 9 in each; P = 0.045). The relative amount of p27 was significantly reduced in atrial tissue from chronic AF patients compared with that from the NSR group (32 ± 63% versus 100 ± 20; n = 9 in each; P = 0.014) (Figure 4 ). Electron microscopic analysis: Myocardiocytes in atrial tissue from chronic AF patients contained mitochondria with swollen cristae and numerous vacuoles within their cytoplasm. Some sarcomeres had no banding pattern and showed the loss of integrity of the contractile elements. Nuclei with chromatin condensation were often fragmented, although their nuclear membranes appeared to be intact. Some apoptotic bodies were seen in the capillary lumen ( Figure 5 ). Myocardiocyte contains mitochondria with swollen cristae and numerous vacuoles within its cytoplasm. Some sarcomeres have no banding pattern and show the loss of integrity of the contractile elements. The nucleus with chromatin condensation is fragmented, but nuclear membrane appears to be intact. Inset; apoptotic body in the capillary lumen.
DISCUSSION
Recent biotechnological advances in DNA microarray have made it possible to investigate the changes in the mRNA of thousands of genes. 14) In the present study, it was shown that chronic AF tissue had a distinct gene expression. Cyclindependent kinase 1A (Cdkn 1a; p21) was also the most significantly changed gene. The changes in p21 were further confirmed by Western blot analysis. Distinct cellular alterations that occurred in AF may also contribute to its perpetuation. In human atrial biopsies or in animal models of AF, a number of myocytes lose their sarcomeric apparatus, which is replaced by the accumulation of glycogen granules. 4, 5) Because these abnormal myocytes re-express some fetal proteins, it has been proposed that they are dedifferentiated, reflecting a certain degree of adaptation of the atrial myocardium to changes in its working conditions, a process that may be reversible. 4) It is also conceivable that as the result of the persistence of pathogenic factors such as an increased pressure load or high frequency of beating, some of the myocytes with structural alterations could activate a programmed cell death pathway.
Apoptosis is a process through which a multicellular organism efficiently disposes of cells. Apoptosis in the heart has been reported to play a role in postnatal morphogenesis, but is also likely to be present in various cardiomyopathies. 1, 15, 16) Apoptotic regulation seems to be involved in multiple pathways, resulting in either apoptosis induction or inhibition. The atrial apoptosis observed in patients with AF could be related to either the cause of chronic AF or the consequence of the arrhythmia. The mechanisms underlying the cellular alterations seen in diseased atria are still poorly understood. With DNA gel electrophoresis, it was possible to identify DNA laddering in cardiac tissue from chronic AF subjects. It is therefore likely that apoptosis is a frequently occurring phenomenon in chronic AF. The biological process is regulated by proteins such as members of the Bcl-2 family, and whereas expression of the proapoptotic protein Bax was the same in all specimens studied, it was found that the expression level of the antiapoptotic protein Bcl-2 was reduced in the specimens of fibrillated atrial myocardium. Aime-Sempe, et al 9) reported the same results as in our study. In their study, Bax and Bcl-2 were expressed in the control and fibrillated atria, but Bcl-2 expression was down-regulated in atrial tissue from patients with chronic AF, suggesting that in the human heart the ratio of Bcl-2 to Bax may play a key role in the balance between life and death.
The action of angiotensin II is initiated by binding to AT1-R/AT2-R. Stimulation of AT1-R induces myocardial hypertrophy and the accumulation of extracellular matrix proteins and also affects atrial contractility. 17, 18) In contrast, stimulation of AT2-R inhibits the proliferative processes. 19) However, the expres-Vol 46 No 3 sion of AT1-R and AT2-R in atrial fibrillation has been controversial. Goette, et al 10) reported that AT1-R is down-regulated and AT2-R is up-regulated in fibrillating right atria. Other investigators claim that AT1-R is upregulated in fibrillating left atria, whereas AT2-R remains unchanged. 20) Although these differences may be explained by the combined heart disease, types of sample, and time course of receptor expression, a definitive reason remains unclear. The regulation of atrial AT1-R/AT2-R expression in patients with chronic AF was observed in the present study. Chronic AF was associated with up-regulation of the AT2-R. However, the expression of AT1-R was not significantly altered. This study showed that chronic AF is associated with an imbalance of the atrial expression of AT1-R and AT2-R. A reduction in AT1-R and increase in AT2-R may, therefore, be compensatory for inhibiting the progression of angiotensin II-dependent interstitial fibrosis.
Cyclin-dependent kinase inhibitors (CDKI) are powerful inhibitors of the cell cycle and may play a direct role in myocyte development and in preventing cell division in adults. The principle negative regulators of the cell cycle are the CDKIs, of which there are two families: the INKs and the CIP/KIPs. The proteins p21 and p27 might use different mechanisms to regulate cell death. [21] [22] [23] The p21 protein is known to be an apoptosis-inducing agent. When the DNA is damaged, an up-regulation of p21 expression will lead to arrest of the cell cycle in order to provide time for DNA repair or to induce apoptosis if DNA repair is inadequate, impossible, or insufficient. However, Maejima, et al 24) described p21 as a modulator rather than inducer in the apoptosis of cardiomyocytes. They showed that the p21 protein was increased in ischemia/reperfusion induced apoptosis in cardiomyocytes, and this change was suppressed by L-NAME and was facilitated by SNAP, suggesting that NO attenuates the apoptosis through the up-regulation of the p21 protein. In the present study, the up-regulation of p21 was observed in chronic AF. However, whether this up-regulation of p21 is associated with atrial tissue apoptosis or cytoprotection of atrial tissue apoptosis in chronic AF is not clear. The function of p27 in the apoptotic process in chronic AF remains unclear. Although overexpression of p27 can induce protection from apoptosis, other studies have reported proapoptotic effects. 25, 26) Burton, et al 27) showed that in both acute and end-stage heart failure, the expression of p21 and p27 was decreased. In the present study, the down-regulation of p27 in chronic AF was observed. Further investigation is required to elucidate the potential link between altered cyclin-dependent kinase inhibitor expression and apoptosis. Conclusion: An increased Bax/Bcl-2 ratio, decreased AT1-R/AT2-R ratio, upregulated p21, and down-regulated p27 may be related to apoptosis. In conclusion, the expressions of Bcl-2, AT2-R, p21, and p27 in fibrillated myocytes in human hearts may play important roles in the progression of cellular damage after atrial fibrillation. Further study on the effects of drugs that modulate the expression of these proteins in patients with chronic AF will be needed.
